INVA vs. OCUL
INVA (Innoviva, Inc.) and OCUL (Ocular Therapeutix, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, INVA returned 5.03%/yr vs 6.96%/yr for OCUL. Their 0.25 correlation means their historical movements had little consistent relationship.
Performance
INVA vs. OCUL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, INVA achieves a 4.90% return, which is significantly higher than OCUL's -32.70% return. Over the past 10 years, INVA has underperformed OCUL with an annualized return of 5.03%, while OCUL has yielded a comparatively higher 6.96% annualized return.
INVA
- 1D
- -1.18%
- 1M
- -6.01%
- 6M
- 4.85%
- YTD
- 4.90%
- 1Y
- 12.56%
- 3Y*
- 16.22%
- 5Y*
- 8.14%
- 10Y*
- 5.03%
- ALL TIME*
- 1.79%
OCUL
- 1D
- -3.54%
- 1M
- -15.25%
- 6M
- -10.61%
- YTD
- -32.70%
- 1Y
- -31.46%
- 3Y*
- 23.00%
- 5Y*
- -5.79%
- 10Y*
- 6.96%
- ALL TIME*
- -3.79%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
INVA Innoviva, Inc. | $12.98M | $16.47M | $18.69M |
| $16.61M | $18.92M | $24.77M |
INVA vs. OCUL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
INVA Innoviva, Inc. | 4.90% | 15.22% | 8.17% | 21.06% | -23.19% | 39.23% | -12.50% | -18.85% | 22.97% | 32.62% |
OCUL Ocular Therapeutix, Inc. | -32.70% | 42.15% | 91.48% | 58.72% | -59.68% | -66.33% | 424.05% | -0.75% | -10.56% | -46.83% |
Correlation
The correlation between INVA and OCUL is 0.23, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.23 |
Correlation (3Y) Balances recent behavior with more history. | 0.24 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.25 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.26 |
Correlation (All Time) Calculated using the full available price history since Jul 25, 2014 | 0.25 |
Fundamentals
INVA:
$1.55B
OCUL:
$1.79B
INVA:
$5.93
OCUL:
-$1.38
INVA:
4.20
OCUL:
33.02
INVA:
1.23
OCUL:
3.15
INVA:
$424.12M
OCUL:
$52.04M
INVA:
$323.16M
OCUL:
$45.40M
INVA:
$438.91M
OCUL:
-$283.03M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
INVA vs. OCUL — Risk / Return Rank
INVA
OCUL
INVA vs. OCUL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Innoviva, Inc. (INVA) and Ocular Therapeutix, Inc. (OCUL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| INVA | OCUL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.95 | ||
| Sortino ratioReturn per unit of downside risk | +1.33 | ||
| Omega ratioGain probability vs. loss probability | 1.12 | 0.97 | +0.15 |
| Calmar ratioReturn relative to maximum drawdown | 0.76 | -0.52 | +1.28 |
| Martin ratioReturn relative to average drawdown | 1.78 | -0.88 | +2.66 |
Loading charts...
Drawdowns
INVA vs. OCUL - Drawdown Comparison
The maximum INVA drawdown since its inception was -84.32%, smaller than the maximum OCUL drawdown of -95.19%. Use the drawdown chart below to compare losses from any high point for INVA and OCUL.
Loading charts...
Drawdown Indicators
| INVA | OCUL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -84.32% | -95.19% | +10.87% |
Max Drawdown (1Y)Largest decline over 1 year | -20.32% | -57.29% | +36.97% |
Max Drawdown (3Y)Largest decline over 3 years | -23.53% | -61.57% | +38.04% |
Max Drawdown (5Y)Largest decline over 5 years | -47.01% | -82.77% | +35.76% |
Max Drawdown (10Y)Largest decline over 10 years | -59.57% | -90.94% | +31.37% |
Current DrawdownCurrent decline from peak | -34.43% | -81.12% | +46.69% |
Average DrawdownAverage peak-to-trough decline | -44.61% | -76.62% | +32.01% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.69% | 33.51% | -24.82% |
Volatility
INVA vs. OCUL - Volatility Comparison
The current volatility for Innoviva, Inc. (INVA) is 6.96%, while Ocular Therapeutix, Inc. (OCUL) has a volatility of 14.69%. This indicates that INVA experiences smaller price fluctuations and is considered to be less risky than OCUL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| INVA | OCUL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.96% | 14.69% | -7.73% |
Volatility (6M)Calculated over the trailing 6-month period | 18.49% | 54.04% | -35.55% |
Volatility (1Y)Calculated over the trailing 1-year period | 29.31% | 69.97% | -40.66% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 27.44% | 78.48% | -51.04% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.55% | 78.42% | -44.87% |
Dividends
INVA vs. OCUL - Dividend Comparison
Neither INVA nor OCUL has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
INVA Innoviva, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 7.12% |
OCUL Ocular Therapeutix, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
INVA vs. OCUL - Financials Comparison
This section allows you to compare key financial metrics between Innoviva, Inc. and Ocular Therapeutix, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
INVA and OCUL have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
OCUL has higher volatility (14.69%) compared to INVA (6.96%). In terms of maximum drawdown, INVA dropped -84.32% vs OCUL's -95.19%.
INVA currently has the higher Sharpe Ratio (0.53 vs -0.42), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for INVA and OCUL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer